PlainPharmaWatch

CMS Open Payments · Program Year 2024

Day One Biopharmaceuticals

Day One Biopharmaceuticals reported $703,048.44 in payments to 191 physicians and teaching hospitals across 441 transactions.

See the rankings → How this is sourced
$703.0K
Total payments
441
Transactions
191
Recipients
#694
of 1,925 companies

Day One Biopharmaceuticals reported $703,048.44 in payments to 191 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #694 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $3.7K per recipient across 5 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Day One Biopharmaceuticals pairs above-median payment volume with a broadly spread payment pattern across many recipients.

#694
of 1,925 companies
0.0%
of all US industry payments
0.2%
paid to its single top recipient
5
payment categories

How Day One Biopharmaceuticals ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Day One Biopharmaceuticals's total vs. every reporting company

CMS Open Payments, Program Year 2024

$703,048 Top 36% higher than 64% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). This entry sits in this band. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Day One Biopharmaceuticals

Day One Biopharmaceuticals ranks #694 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $703,048.44 across 441 transactions to 191 physicians and teaching hospitals - $1.6K per transaction and $3.7K per recipient on average.

"Consulting Fee" leads the 5-category general-payment breakdown below at $116.6K (16.6% of the company's reported total, 32 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

"Consulting Fee" leads Day One Biopharmaceuticals's 5-category general-payment breakdown at $116.6K, 16.6% of the reported total.

How Day One Biopharmaceuticals divides its payments

General-payment categories, ordered by reported total

1. Consulting Fee$116.6K2. Compensation for Services…$50.3K3. Travel and Lodging$15.8K4. Food and Beverage$6.0K5. Space Rental or Facility …$3.0K
Payment Type Amount Transactions
Consulting Fee $116.6K 32
Compensation for Services Other Than Consulting $50.3K 15
Travel and Lodging $15.8K 30
Food and Beverage $6.0K 113
Space Rental or Facility Fees $3.0K 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $109,218.65 (57.0%) of $191,705.30 in this company's General Payments records across 102 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Day One Biopharmaceuticals

The five named recipients with the highest reported General Payments from this company

Caroline Hastings$34.2KDaniel Landi$27.9KAmy Smith$20.1KBridget Archambault$17.7KMohamed Abdel-Baki$9.2K
  1. 1

    Caroline Hastings

    $34,245.90 across 26 reported transactions

  2. 2

    Daniel Landi

    $27,934.49 across 11 reported transactions

  3. 3

    Amy Smith

    $20,090.63 across 9 reported transactions

  4. 4

    Bridget Archambault

    $17,737.63 across 23 reported transactions

  5. 5

    Mohamed Abdel-Baki

    $9,210.00 across 9 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $1.6K. Average per recipient: $3.7K.

Total Amount

$703,048.44

Avg per Transaction

$1.6K

Avg per Recipient

$3.7K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Day One Biopharmaceuticals Share

0.0%

#694 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Day One Biopharmaceuticals

Calvary Spine, LLC

$703.2K 0 recipients

SurGenTec

$704.8K 249 recipients

Napo Pharmaceuticals Inc

$704.8K 1,430 recipients

Kuros Biosciences USA, Inc

$711.3K 1,447 recipients

Kaneka Medical America LLC

$691.1K 202 recipients

Scilex Pharmaceuticals Inc.

$715.7K 19,348 recipients

Frequently Asked Questions

How much did Day One Biopharmaceuticals pay to physicians and hospitals in 2024? ▾
Day One Biopharmaceuticals made $703,048.44 in payments to physicians and hospitals in Program Year 2024, across 441 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Day One Biopharmaceuticals? ▾
191 physicians and teaching hospitals received payments from Day One Biopharmaceuticals in 2024, averaging $3.7K per recipient.
What types of payments did Day One Biopharmaceuticals make? ▾
General payments from Day One Biopharmaceuticals span 5 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Consulting Fee" at $116.6K, representing 16.6% of the company's reported total.
How does Day One Biopharmaceuticals rank among pharmaceutical companies? ▾
By total payment amount, Day One Biopharmaceuticals sits at #694 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Day One Biopharmaceuticals? ▾
Day One Biopharmaceuticals's 441 transactions to 191 recipients in 2024 averaged $1.6K per transaction.
Where does the payment data for Day One Biopharmaceuticals come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Day One Biopharmaceuticals's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.